Earnings · China A-shares
Shanghai Pharmaceuticals Holding Co. Ltd. Class A (601607) earnings
Shanghai Pharmaceuticals Holding Co. Ltd. Class A published its Q3 report on 2026-10-29: net profit -10.90% year on year, +25.02% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +3.29% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -10.90%
- Excl. one-offs YoY
- +25.02%
- Net profit QoQ
- -48.17%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.55% | — |
| 3 days | +3.29% | — |
| 7 days | +0.67% | — |
| 14 days | +1.40% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +0.05%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥4.59B | -10.90% | +25.02% | +3.67% | 1.24 | 5.90% | +3.29% | — | — |
| 2026 interim report | 2026-08-28 | ¥3.50B | -21.40% | +17.98% | +4.15% | 0.95 | 4.51% | +0.74% | +2.09% | +11.78% |
| 2026 Q1 report | 2026-04-30 | ¥1.42B | +6.35% | -2.02% | +6.36% | 0.38 | 1.85% | +1.18% | -3.84% | -5.89% |
| 2025 annual report | 2026-03-31 | ¥5.72B | +25.74% | -26.68% | +3.03% | 1.54 | 7.74% | +3.15% | -0.42% | -8.84% |
| 2025 Q3 report | 2025-10-31 | ¥5.15B | +26.96% | -26.79% | +2.60% | 1.39 | 6.96% | -2.73% | -2.78% | +1.90% |
| 2025 interim report | 2025-08-29 | ¥4.46B | +51.56% | -22.38% | +1.56% | 1.20 | 6.03% | -1.85% | -4.22% | -5.50% |
| 2025 Q1 report | 2025-04-29 | ¥1.33B | -13.56% | -8.10% | +0.87% | 0.36 | 1.84% | -1.21% | +1.21% | -1.37% |
| 2024 annual report | 2025-03-28 | ¥4.55B | +20.82% | +13.04% | +5.75% | 1.23 | 6.50% | -2.16% | -5.46% | -4.37% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.